WHO decision challenges West to recognize Chinese vaccines – News Vibe24

    WHO decision challenges West to recognize Chinese vaccines - Times of India
    GENEVA: The World Health Organization said on Thursday that any Covid-19 vaccines it has approved for emergency use must be recognized by countries as they open their borders to vaccinated travelers.
    The move could prompt Western countries to expand their acceptance of two seemingly less effective Chinese vaccines, which the United Nations health service has approved, but most countries in Europe and North America do not have.
    In addition to Pfizer-BioNTech vaccines, Moderna Inc. AstraZeneca and Johnson & Johnson, the WHO also gave the green light to the two Chinese piercings, made by Sinovac and Sinopharm.
    Aiming to restore travel across Europe, the European Union said in May that it would only recognize people as vaccinated if they had received shots fired with a license from the European Medicines Agency – although it is up to individual countries if they wish to allow travelers to have received other vaccines, including Sputnik V.
    The EU drug regulator is currently considering licensing China’s Sinovac vaccine, but there is no timetable for a decision. It also does not recognize versions of the AstraZeneca vaccine made in India, effectively banning travel for people in developing countries receiving doses through the UN-supported initiative known as COVAX.
    “Any measure that only allows people protected by a WHO-approved subset of vaccines to benefit from the travel opening … will effectively create a two-tier system, further widening the global vaccine gap and exacerbating “We have already seen the distribution of Covid-19 vaccines,” the WHO said in a statement on Thursday. “It would negatively affect the growth of economies that are already suffering the most.”
    The WHO said such moves undermine “confidence in rescue vaccines that have already been shown to be safe and effective.” In its reviews of the two Chinese vaccines, the UN health service said both were found to significantly reduce the risk of hospitalization and death.
    The two Chinese shots are “inactivated” vaccines, made with a dead coronavirus, while the western shots are made with newer technologies that instead target the “spike” protein that covers the surface of the coronavirus.
    Although Western countries have relied heavily on vaccines made in the US and Europe, such as Pfizer-BioNTech and AstraZeneca, many developing countries have used the shots from China.
    Earlier this year, the head of China’s Centers for Disease Control and Prevention acknowledged that the effectiveness of its domestic shootings was low. Many countries that have used millions of doses from the two Chinese shots, including the Seychelles and Bahrain, have seen Covid-19 rise even with relatively high levels of immunization.


    Newsvibe24 Source